Oakmont Partners »

Corcept Therapeutics Incorporated shares owned by Oakmont Partners

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Oakmont Partners from 13F filings

Historical chart of Oakmont Partners investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Oakmont Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Oakmont Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.5M 30k 50.39
2024-09-30 $1.4M 30k 46.28
2024-06-30 $981k 30k 32.49
2024-03-31 $761k 30k 25.19
2023-12-31 $981k 30k 32.48
2023-09-30 $823k 30k 27.25
2023-06-30 $672k 30k 22.25
2023-03-31 $654k 30k 21.66
2022-12-31 $613k 30k 20.31
2022-09-30 $774k 30k 25.63

More positions owned by Oakmont Partners

Kla Corp Com New (KLAC)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Costco Wholesale Corporation (COST)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Oakmont Partners

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jacobs Levy Equity Management
FMR
Morgan Stanley
First Trust Advisors
Charles Schwab Investment Management
Northern Trust

View all funds holding Corcept Therapeutics Incorporated